Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

699
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
699
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

841
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
841
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

196
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
196
Lipid Digestion01:06

Lipid Digestion

92.2K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
92.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlates of Obesity Medication Use in Paediatric Weight Management Programmes: A POWER Consortium Analysis.

Pediatric obesity·2026
Same author

Cardiovascular Disease and Dyslipidemia in Pediatric Type 1 Diabetes.

Current atherosclerosis reports·2026
Same author

Unsupervised Phenotyping of Asthma: Integrating Serum Periostin with Clinical and Inflammatory Profiles.

Diagnostics (Basel, Switzerland)·2025
Same author

Evaluating continuous nanosecond pulsed electric field (nsPEF) treatment as a non-thermal alternative for human milk pasteurisation.

PloS one·2025
Same author

A Framework for Evaluation of New Processing Technologies in Human Milk Banking.

Comprehensive reviews in food science and food safety·2025
Same author

Estimation of Blood Utilization in Elective Surgeries to Formulate Maximum Surgical Blood Ordering Schedule for a Tertiary Care Center in North India.

International journal of applied & basic medical research·2025

Related Experiment Video

Updated: Jul 20, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

Algorithms for Treating Dyslipidemia in Youth.

Grace K Kim1, Jennifer K Yee2,3, Nidhi Bansal4

  • 1Division of Diabetes and Endocrinology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, 6701 Fannin St. Ste 1020, Houston, TX, 77030, USA.

Current Atherosclerosis Reports
|July 31, 2023
PubMed
Summary

Pediatric dyslipidemia is undertreated. Enhanced algorithms incorporating new pharmacotherapy can improve management and reduce cardiovascular disease (CVD) risk in youth.

Keywords:
AlgorithmsCardiovascular diseaseDyslipidemiaLipidsYouth

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.3K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.1K

Related Experiment Videos

Last Updated: Jul 20, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.3K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.1K

Area of Science:

  • Pediatric Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Childhood cardiovascular disease (CVD) risk factors predict adult events.
  • Early statin therapy in familial hypercholesterolemia reduces adult CVD risk.
  • Pediatric dyslipidemia is often undertreated due to provider knowledge gaps.

Purpose of the Study:

  • Review current dyslipidemia treatment algorithms for youth.
  • Identify and address management pitfalls.
  • Propose enhanced algorithms with updated pharmacotherapy.
  • Consider future directions in pediatric dyslipidemia management.

Main Methods:

  • Review of existing pediatric dyslipidemia management guidelines.
  • Analysis of recent pharmacotherapy approvals.
  • Development of enhanced treatment algorithms.
  • Discussion of clinical risk assessment tools.

Main Results:

  • Current algorithms exist but have management gaps.
  • Enhanced algorithms incorporate novel pharmacotherapy.
  • Improved risk assessment tools are needed for tailored management.
  • Early intervention in youth can mitigate adult CVD risk.

Conclusions:

  • Enhanced algorithms can improve pediatric dyslipidemia management.
  • Addressing provider education is crucial.
  • Further research into risk stratification is warranted.
  • Optimizing treatment in youth is key to preventing adult CVD.